NCT05965063View on ClinicalTrials.gov

The Role of Bifidobacterium Intervention in Food Allergic Infants

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2025

Conditions
Food Allergy in Infants
Interventions
DIETARY_SUPPLEMENT

Bifidobacterium M-16V

Bifidobacterium M-16V was dosed at 10 billion colony forming unit (CFU) (equal to 6 drops)/day for 12 weeks.

OTHER

allergy food avoidance

strict avoidance of the specific allergenic food

Trial Locations (1)

021

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER

NCT05965063 - The Role of Bifidobacterium Intervention in Food Allergic Infants | Biotech Hunter | Biotech Hunter